Intuniv (in-TOO-niv), a new extended-release guanfacine for ADHD

November 2009

Reps will promote Intuniv (in-TOO-niv), a new extended-release guanfacine for ADHD.

It'll be used as an alternative or add-on to stimulants.

Guanfacine is an old antihypertensive that's been used off-label for years for ADHD...but it's dosed up to 3 times a day.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

meds adjusted due to bariatric surgery
Influenza giving acetaminophen to children before vaccinations MIGHT reduce immunity
Influenza Compounded Tamiflu suspension and Relenza are leading to problems
Cardiology whether proton pump inhibitors decrease the efficacy of clopidogrel (Plavix)
Women's Health how to switch women from oral to topical estrogens
Women's Health whether ginger is safe during pregnancy
Anticoagulants whether dosage changes are needed for the new, LOWER-potency unfractionated heparin
Dermatology new injectable biologic for moderate to severe plaque psoriasis called Stelara (stel-AR-a)
Neurology & Pain new IV version of ibuprofen, Caldolor
Pediatrics Intuniv (in-TOO-niv), a new extended-release guanfacine for ADHD
Infectious Diseases new IV antibiotic for methicillin-resistant Staph aureus (MRSA) infections, Vibativ (vy-BA-tiv)
supplements for colds and flu
Diabetes new warnings about reports of acute pancreatitis with sitagliptin (Januvia, Janumet)